Tempus AI, Inc. remains a Hold due to valuation & lack of profitability; shows strong revenue growth & diversification. Learn ...
Tempus AI has surged ~75% since August, but current valuations (~15x EV/forward revenue) are unsustainable for its hybrid ...
Tempus AI, Inc. TEM continues to strengthen its position in precision medicine through strategic acquisitions. In a move to expand its digital pathology capabilities, the company announced the $81.25 ...